Victor W. Henderson
Academic Appointments
- Professor, Health Research & Policy - Epidemiology
- Professor, Neurology & Neurological Sciences
Key Documents
Contact Information
-
Clinical Offices
Neurology Clinic 300 Pasteur Dr A301 MC 5325 Stanford, CA 94305 Tel Work (650) 723-6469 Fax (650) 498-6326
- Academic Offices
Personal Information Tel (650) 723-5456Alternate Contact Toni Ali Adminstrative Associate Email Tel Work 723-5456Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Memory Disorders
- Neurology
Administrative Appointments
- Director, Graduate Program in Epidemiology, Stanford University (2004 - present)
- Chief, Division of Epidemiology (2010 - present)
- Senate Steering Committee, Faculty Senate, School of Medicine (2008 - 2012)
- Committee on Graduate Studies, Stanford University (2009 - 2012)
Honors and Awards
- Chair, Geriatric Neurology Section, American Academy of Neurology (2008-2011)
- Kenneth and Bette Volk Endowed Professorship, University of Southern California (1999-2001)
- Visiting Professor / Visiting Research Scholars Award, University of Melbourne / University of Melbourne Collaborative Research Program (2002)
- Visiting Scientist, Massachusetts Institute of Technology (1988-1989)
- President, North American Menopause Society (2007-2008)
- Kearney Visiting Professor, Mental Health Research Institute of Victoria (2002)
Professional Education
| MD: | Johns Hopkins University, Medicine |
| MS: | University of Washington, Epidemiology |
| Internship: | Duke University, Internal medicine |
| Residency: | Washington University, Neurology |
| Fellowship: | Boston University, Behavioral Neurology |
| Board Certification: | Behavioral Neurology and Neuropsychiatry, United Council for Neurologic Subspecialties (2006) |
Graduate & Fellowship Program Affiliations
Scientific Focus
Current Research Interests
Research interests:
(1) Risk factors for age-associated cognitive decline and dementia,
(2) Therapeutic strategies to improve cognitive function in aging and dementia, and
(3) Brain–behavior relations as they pertain to human cognition.
Our research focuses on pharmacological and behavioral interventions to remediate cognitive aging and to improve symptoms of dementia. One major emphasis concerns the role of estrogens and other sex steroids in human cognition and dementia.
Clinical Trials
- Not Recruiting ACE-Seniors (Activities for Cognitive Enhancement of Seniors)
- Not Recruiting Raloxifene for Women With Alzheimer's Disease
Publications
- Long-term soy isoflavone supplementation and cognition in women: a randomized, controlled trial. Neurology. 2012; (23): 1841-8
- Alzheimer's disease: Review of hormone therapy trials and implications for treatment and prevention after menopause. J Steroid Biochem Mol Biol. 2013
- Memantine is Associated with Longer Survival than Donepezil in a Veterans Affairs Prescription Database, 1997 to 2008. J Alzheimers Dis. 2013
- Supply and demand analysis of the current and future US neurology workforce. Neurology. 2013
- Effects of physical activity on vasomotor symptoms: examination using objective and subjective measures. Menopause. 2012; (10): 1095-103
- Estrogens and Alzheimer disease risk: is there a window of opportunity? Neurology. 2012; (18): 1840-1
Help